Shoulder Anterior Capsular Block and Intraarticular Steroid Injection Versus Intraarticular Steroid Injection for Enhancing Pain Relief in Adhesive Capsulitis

NCT07235982 | Recruiting

• 1 other identifier: 1593
• Study Type: interventional
• Target: 50
• Locations: 1 country
• Sites: 1

Brief Summary

Improving pain in the patients with adhesive capsulitis by comparing the effect of combined shoulder anterior capsular block and intraarticular steroid injection versus intraarticular steroid injection.

Conditions

Analgesia

Keywords

shoulder anterior capsular block; intraarticular steroid injection; adhesive capsulitis

Outcome Measures

Primary Outcomes (7)

• pain intensity

  measured by Visual Analogue Scale (VAS) 10 cm line labelled (0-10), in which 0 presents no pain and 10 represents the worst pain in each participant

  BEFORE STARTING PROCEDURE (0 hour)(baseline)

• pain intensity

  measured by Visual Analogue Scale(VAS) as 10 cm line labelled (0-10), in which 0 presents no pain and 10 represents the worst pain in each participant

  15 minutes after the procedure

• pain intensity

  measured by Visual Analogue Scale (VAS) 10 cm line labelled (0-10), in which 0 presents no pain and 10 represents the worst pain in each participant

  first 6 hours postoperative

• pain intensity

  measured by Visual Analogue Scale (VAS) 10 cm line labelled (0-10), in which 0 presents no pain and 10 represents the worst pain in each participant

  one week after procedure

• pain intensity

  measured by Visual Analogue Scale (VAS) 10 cm line labelled (0-10), in which 0 presents no pain and 10 represents the worst pain in each participant

  3 weeks after procedure

• pain intensity

  measured by Visual Analogue Scale (VAS) 10 cm line labelled (0-10), in which 0 presents no pain and 10 represents the worst pain in each participant

  6 weeks after procedure

• pain intensity

  measured by Visual Analogue Scale (VAS) 10 cm line labelled (0-10), in which 0 presents no pain and 10 represents the worst pain in each participant

  8 weeks after procedure

Secondary Outcomes (5)

• Assessment of Shoulder Pain and Disability Index (SPADI)

  baseline (0 ) and subsequently at one week, 3 weeks , 6 weeks and 8 weeks after procedure

• Total amount of rescue analgesia

  first 24 hours

• patient's satisfaction

  1 week after procedure

• Complications of SHAC block

  24 hours

• PASSIVE AND ACTIVE RANGE OF MOTION

  at baseline, first week and third week follow up post intervention.

Study Arms (2)

Group Shoulder anterior capsular block (SHAC)

ACTIVE COMPARATOR

patients will receive ultrasound guided (SHAC) block combined with intraarticular steroid injection of the affected shoulder joint

Procedure: Group Group Shoulder anterior capsular block (SHAC)

Group intraarticular steroid injection (IASI)

ACTIVE COMPARATOR

patients will receive intraarticular steroid injection of the affected shoulder joint

Procedure: Group intraarticular steroid injection (IASI)

Interventions

Group Group Shoulder anterior capsular block (SHAC) PROCEDURE

patients will receive ultrasound guided (SHAC) block combined with intraarticular steroid injection of the affected shoulder joint followed by home exercise program.

Group Shoulder anterior capsular block (SHAC)

Group intraarticular steroid injection (IASI) PROCEDURE

patients will receive intraarticular steroid injection of the affected shoulder joint followed by home exercise program

Group intraarticular steroid injection (IASI)

Eligibility Criteria

• Age: 41 Years - 65 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Patients acceptance
• Age: 41-65 years old
• Sex: both sex (males or females).
• Physical status: American Society of Anesthesiologist (ASA) І, II.
• Patients attend orthopedic or pain clinic with complaint of shoulder pain and stiffness. These patients received conservative management of pain with no relief of symptoms for at least 2 weeks.

You may not qualify if:

• Shoulder pain due to secondary causes, e.g. acute trauma, fractures, bony deformity, glenohumeral joint pathology, acromioclavicular joint pathology and rotator cuff disorder.
• Patient with any contraindications of regional blocks (as coagulopathy or local infection at injection site)
• Patients with known history of allergy to the study drugs (bupivacaine and methylprednisolone).
• Advanced hepatic, renal, cardiovascular, neurologic and respiratory diseases, uncontrolled diabetes mellitus and thyroid.
• History of neuropathy in the involved limb or previous revision surgery.

Sponsors & Collaborators

• Zagazig University: lead

Study Sites (1)

Faculity of Medicine, Zagazig University

Zagazig, Egypt

RECRUITING

MeSH Terms

Conditions

Agnosia; Bursitis

Condition Hierarchy (Ancestors)

Perceptual Disorders; Neurobehavioral Manifestations; Neurologic Manifestations; Nervous System Diseases; Signs and Symptoms; Pathological Conditions, Signs and Symptoms; Joint Diseases; Musculoskeletal Diseases

Study Officials

• Dina Salem, MD

  FACULTY OF MEDICINE, ZAGAZIG UNIVERSITY

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Dina Salem, MD

CONTACT

01099333513; dinamaghraby@yahoo.com

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: OUTCOMES ASSESSOR
• Masking Details: The outcome assessors are blind to the study groups
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER GOV
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: principle investigator

Model Details: pain relief in adhesive capsulitis by comparing shoulder anterior capsular block and intraarticular steroid injection versus intraarticular steroid injection

Study Record Dates

• First Submitted: September 29, 2025
• First Posted: November 19, 2025
• Study Start: October 1, 2025
• Primary Completion: May 1, 2026
• Study Completion (Estimated): June 1, 2026
• Last Updated: November 19, 2025

Record last verified: 2025-11

Data Sharing

• IPD Sharing: Will not share

Locations

EG (1)